Community Health has reached an agreement with the city to make annual payments over the next 25 years instead of paying ...

SBQuantum announced the launch of Diamond Polaris 1, a small satellite that will test the company’s novel approach to ...

CPD accredited public sector news, comment & analysis for Civil Servants responsible for building, shaping and delivering ...

Beam Therapeutics (BEAM) stock jumps as the company seeks to move gene-editing drug BEAM-302 to pivotal study in.alpha-1 ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Ruivivar, a gymnast at Stanford, and Xander Sielken, a baseball player at CSU Monterey Bay, have been selected as the ...

Invivoscribe, a global leader in precision diagnostics and measurable residual disease (MRD) testing, is proud to announce that its IdentiClone Dx IGH Assay has received In Vitro Diagnostic Regulation ...

We caught up with Omaha’s first baby, 40 years after she made headlines in 1979, to find out what it’s like to grow up a New ...

The current price of Beam (BEAM) is $0.0016562, as of Mar 27, 2026. Over the last 24 hours, the price has moved by -2.15%, with a change of -1.23% in the past hour. For longer-term performance, the ...

Find the latest Beam Therapeutics Inc. (BEAM) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.